Name: Xdemvy
Indications: To treat Demodex blepharitis.
Active Ingredient: Lotilaner
Company: Tarsus Pharmaceuticals, Inc.
Approval Date: 7/25/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf
Name: Xdemvy
Indications: To treat Demodex blepharitis.
Active Ingredient: Lotilaner
Company: Tarsus Pharmaceuticals, Inc.
Approval Date: 7/25/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf